Seven of the top 10 drugs that inflated U.S. healthcare spending in 2020 due to price increases did not offer substantial clinical benefits.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}